Inotropic drugs and their mechanisms of action

This report describes various old and new positive inotropic drugs with respect to their mechanisms of action. Drugs with established cardiotonic effects include cardiac glycosides, beta 1-adrenergic agents, glucagon, histamine and the methylxanthines. New agents discussed are prenalterol, beta 2- and alpha-adrenergic drugs, amrinone and sulmazole. Prenalterol is a beta 1-adrenergic agent. Beta 2-adrenergic drugs, amrinone and sulmazole, combine a positive inotropic and a vasodilator effect. The latter resemble theophylline and other methylxanthines in that they appear to act mainly as phosphodiesterase inhibitors with a subsequent increase in cyclic adenosine monophosphate (cAMP). The mechanism of the positive inotropic effect of alpha-adrenergic stimulating agents (for example, phenylephrine) is unknown. It is independent of the cAMP system and is not accompanied by changes in frequency.

This article has been cited by other articles:

				S. A. McDowell, E. McCall, W. F. Matter, T. B. Estridge, and C. J. Vlahos Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H796 - H805. [Abstract] [Full Text] [PDF]

				J. Neumann A renaissance of positive inotropic interventions to treat heart failure? Cardiovasc Res, September 1, 2003; 59(3): 534 - 535. [Full Text] [PDF]